HBV COVALENTLY CLOSED CIRCULAR DNA AS A MARKER OF PREVALENCE OF OCCULT HEPATITIS В IN PATIENTS WITH HBV, HDV AND HCV INFECTION IN UZBEKISTAN
- Authors: Semenov A.V.1,2,3, Ostankova Y.V.1, Faizullaev K.N.4, Kazakova E.I.4, Kozlov A.V.3, Musabaev E.I.4, Totolyan A.A.1,2
-
Affiliations:
- Pasteur Research Institute of Epidemiology and Microbiology
- Pavlov State Medical University
- Mechnikov North-Western State Medical University
- Research Institute of Virology
- Issue: Vol 93, No 5 (2016)
- Pages: 43-49
- Section: ORIGINAL RESEARCHES
- URL: https://microbiol.crie.ru/jour/article/view/86
- DOI: https://doi.org/10.36233/0372-9311-2016-5-43-49
- ID: 86
Cite item
Full Text
Abstract
About the authors
A. V. Semenov
Pasteur Research Institute of Epidemiology and Microbiology; Pavlov State Medical University; Mechnikov North-Western State Medical University
Author for correspondence.
Russian Federation
Yu. V. Ostankova
Pasteur Research Institute of Epidemiology and MicrobiologyRussian Federation
Kh. N. Faizullaev
Research Institute of VirologyRussian Federation
E. I. Kazakova
Research Institute of VirologyRussian Federation
A. V. Kozlov
Mechnikov North-Western State Medical UniversityRussian Federation
E. I. Musabaev
Research Institute of VirologyRussian Federation
A. A. Totolyan
Pasteur Research Institute of Epidemiology and Microbiology; Pavlov State Medical UniversityRussian Federation
References
- Габдрахманов И.А., Семенов А.В., Останкова Ю.В. идр. Взаимосвязи вирусологических и морфологических показателей в фазах иммунного контроля и реактивации у больных хроническим гепатитом В. Журнал инфектологии. 2015, 7 (4): 37-43.
- Семенов А.В., Власова И.А., Останкова Ю. В., Тотолян Арег А. Количественное определение HBsAg в сыворотке крови и кольцевой ковалентно замкнутой ДНК вируса гепатита В в ткани печени как маркеры активности хронического вирусного гепатита В. Журн. микробиол. 2014, 1: 55-61.
- Alghamdi A., Aref N., El-Hazmi М. et al. Correlation between hepatitis В surface antigen titers and HBV DNA levels. Saudi J. Gastroenterol. 2013, 19 (6): 252-257.
- Branco F., Mattos A.A., Coral G.P. et al. Occult hepatitis В virus infection in patients with chronic liver disease due to hepatitis C virus and hepatocellular carcinoma in Brazil. Arq. Gastroenterol. 2007, 44 (1): 58-63.
- Fukuda R., Ishimura N., Niigaki M. et al. Serologically silent hepatitis В virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J. Med. Virol. 1999, 58: 201-207.
- Georgiadou S.P., Zachou K., Liaskos C. et al. Occult hepatitis В virus infection in patients with autoimmune liver diseases. Liver Int. 2009, 29 (3): 434-442.
- Guo J.T., Guo H. Metabolism and function of hepatitis В virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics. Antiviral Research. 2015, 122: 91-100.
- Huqng X., Hollinger F.B. Occult hepatitis В virus infection and hepatocellular carcinoma: a systematic review. J. Viral Hepat. 2014, 21: 153-162.
- Lozano R., Naghavi M., Foreman K. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis forthe Global Burden of Disease Study 2010. Lancet. 2012, 380: 2095-2128.
- Pollicino T., Squadrito G., Cerenzia G. et al. Hepatitis В virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology. 2004, 126 (1): 102-110.
- Raimondo G., Pollicino T., Cacciola I. et al. Occult hepatitis В virus infection. J. Hepatol. 2007,46: 160-170.
- Ramezani A., Banifazl M., Eslamifar A. et al. Occult hepatitis В infection in different high risk patients. Hepat. Mon. 2012, 12: 467-468.
- Rizvi M., Azam M., Sultan A. et al. Prevalence of genotype D in chronic liver disease patients with occult HBV infection in northern region of India. Indian J. Pathol. Microbiol. 2014, 57 (4): 537-541. •
- Rodriguez-Inigo E., Bartolome J., Ortiz-Movilla N. et al. Hepatitis C virus (HCV) and hepatitis В virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection. J. Virol. 2005, 79 (24): 15578-15581.
- Ruzibakiev R., Kato H., Ueda R. et al. Risk factors and seroprevalence of hepatitis В virus, hepatitis C virus, and human immunodeficiency virus infection in Uzbekistan. Intervirology. 2001,44 (6): 327-332.
- Squadrito G., Cacciola I., Alibrandi A. et al. Impact of occult hepatitis В virus infection on the outcome of chronic hepatitis C. J. Hepatol. 2013, 59 (4): 696-700.
- Torbenson M., Thomas D.L. Occult hepatitis B. Lancet Infect. Dis. 2002, 2: 479-486.
- Wu Z.F., Xu Z., Li W.S. et al. Impact of occult hepatitis В virus infection on outcome after resection fornon-B non-C hepatocellular carcinoma. J. Surg. Res. 2015, 193 (1): 153-160.
Supplementary files


